Preparation of azolylpyrrolidinecarboxylates as hepatitis C virus (HCV) inhibitors.

Autoria(s): Bravi, G.; Goodland, H.S.; Haigh, David; Hartley, C.D.; Lovegrove, V.L.H.; Shah, P.; Slater, M.J.
Data(s)

01/05/2003
Identificador

http://pure.qub.ac.uk/portal/en/publications/preparation-of-azolylpyrrolidinecarboxylates-as-hepatitis-c-virus-hcv-inhibitors(655f9ad6-88bc-445a-85aa-9bfece8e4712).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Bravi , G , Goodland , H S , Haigh , D , Hartley , C D , Lovegrove , V L H , Shah , P & Slater , M J 2003 , Preparation of azolylpyrrolidinecarboxylates as hepatitis C virus (HCV) inhibitors. , Patent No. WO 2003037894 A1 .
Tipo

patent
Acesso ao item digital